Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas
ClinicalTrials.gov study NCT05113069. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors
ClinicalTrials.gov study NCT06567366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma
ClinicalTrials.gov study NCT06834529. IPD Sharing: YES. Countries: 1. Publications: 0.
Induced-T Cell Like NK Cells for B Cell Malignancies
ClinicalTrials.gov study NCT04747093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05228249. IPD Sharing: NO. Countries: 1. Publications: 0.
MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma
ClinicalTrials.gov study NCT06414148. IPD Sharing: NO. Countries: 1. Publications: 0.
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02623920. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in Relapsed or Refractory Extranodal NK/T- Cell Lymphoma, Nasal Type and EBV-associated Diffuse Large B Cell Lymphomas
ClinicalTrials.gov study NCT03586024. IPD Sharing: NO. Countries: 1. Publications: 0.
Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT00836173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT04827004. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases
ClinicalTrials.gov study NCT06318533. IPD Sharing: NO. Countries: 1. Publications: 0.
Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
ClinicalTrials.gov study NCT06784726. IPD Sharing: NO. Countries: 1. Publications: 0.
PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic Leukaemia
ClinicalTrials.gov study NCT03156790. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study
ClinicalTrials.gov study NCT07072494. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT01402440. IPD Sharing: Not stated. Countries: 10. Publications: 0.
Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B Cell Lymphomas
ClinicalTrials.gov study NCT05133505. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
R-ESHAP Followed by Autologous Transplantation for Refractory or Relapsed Diffused Large B-cell Lymphoma
ClinicalTrials.gov study NCT01278602. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL
ClinicalTrials.gov study NCT05114837. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL
ClinicalTrials.gov study NCT04129099. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
ClinicalTrials.gov study NCT06037018. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.